InsidersTradesSigma
Track the ORUKA THERAPEUTICS INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €6bn. The latest transaction was reported on 15 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOANA GONCALVES. All data is free.
Analysts rate ORUKA THERAPEUTICS INC Strong Buy (bullish), based on 12 analysts. Average price target: US$153.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ORUKA THERAPEUTICS INC es una empresa centrada en el desarrollo de terapias innovadoras. Cotiza en el mercado XNAS.